Bo Xu
No. 28, Changsheng West Road
Hengyang, 421001, China
Hengyang, 421001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Complement C5 inhibitor crovalimab for the treatment of paroxysmal nocturnal hemoglobinuria.
Journal: Expert review of clinical pharmacology
Published: May 29, 2026
Impact of sodium glucose cotransporter 2 inhibitors on bladder cancer and breast cancer: a pharmacovigilance analysis and Mendelian randomization study.
Journal: Expert opinion on drug safety
Published: November 24, 2025
Macrophage-like smooth muscle cells in atherosclerosis.
Journal: Molecular biology reports
Published: August 20, 2025
Explore the potential mechanisms between ertugliflozin and kidney cancer through bioinformatics analysis and Mendelian randomization study.
Journal: International journal of surgery (London, England)
Published: August 07, 2025
Association between SGLT2 inhibitors and genital cancer: a meta-analysis and mendelian randomization study.
Journal: Journal of endocrinological investigation
Published: June 25, 2025
Effects of sodium-glucose cotransporter 2 inhibitors on cardiomyopathy: a meta-analysis.
Journal: Journal of endocrinological investigation
Published: April 23, 2025
Association between sodium-glucose cotransporter 2 inhibitors and cancer: a systematic review and meta-analysis of randomized active-controlled trials.
Journal: International journal of clinical pharmacy
Published: February 08, 2025
A comprehensive review of the efficacy and safety of ertugliflozin.
Journal: Expert opinion on drug metabolism & toxicology
Published: January 22, 2025
Role of the E26 transformation specific transcription factor family in metabolic disorders.
Journal: Journal of endocrinological investigation
Published: January 07, 2025
New perspectives on the treatment of diabetic nephropathy: Challenges and prospects of mesenchymal stem cell therapy.
Journal: European journal of pharmacology
Published: November 22, 2024
Investigating Sodium-Glucose Cotransporter 2 Inhibitors Versus Other Glucose-Lowering Drugs on Ventricular Arrhythmias or Sudden Cardiac Death Using the US FDA Adverse Event Reporting System.
Journal: Cardiovascular drugs and therapy
Published: November 14, 2024
Type II RAF inhibitor tovorafenib for the treatment of pediatric low-grade glioma.
Journal: Expert review of clinical pharmacology
Published: October 16, 2024
Last Updated: 09/26/2026